Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

04 Nov 2021

TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was...

Luis Ortega-Paz

Author

Luis Ortega-Paz
Rafael Romaguera

Author

Rafael Romaguera
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

PCRonline @ TCT 2021 - Get the international perspective!

03 Nov 2021

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

PCRonline @ TCT 2021

Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

28 Oct 2021

To further investigate the treatment effects of ticagrelor monotherapy compared with ticagrelor plus aspirin in a contemporary HBR population, a pre-specified analysis of the TWILIGHT trial, TWILIGHT-HBR, was conducted by using the Academic Research Consortium (ARC) criteria for HBR.

Reviewer

Ali Nazmi Calik
Elif Ilkay Yuce

Reviewer

Elif Ilkay Yuce
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

Optimised PCI in real-world complex lesions

09 Oct 2021 – From AICT-AsiaPCR 2021

How to achieve optimised outcomes in complex PCI? This is the question that the speakers will try to answer in this not-to-be-missed session! Understand the role of coronary physiology, learn the algorithm of coronary imaging, and see how to utilise OCT imaging for decision making...

Optimised PCI in real-world

Imaging in stent thrombosis

09 Oct 2021 – From AsiaPCR 2021

Watch this session to learn more about the importance of intracoronary imaging in stent thrombosis and the role of OCT and IVUS in its evaluation, as well as to discover how imaging helps to identify its mechanism and differentiate it from bystander findings and target specific treatment.

Imaging in stent thrombosis

Small but strong - Semi-compliant balloon in complex and complicated PCI case

09 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session about complex and complicated PCI cases to discover strategies that simplify their management, to understand the intricacies of a semi-compliant balloon design, and to learn techniques to expertly utilize such a balloon.

Small but strong - Semi-compliant

Cases on in-stent restenoses

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover a selection of complex cases on in-stent restenosis after PCI, and learn more about the advantages of OCT.

Cases on in-stent restenoses

Cases on complications: stable CAD, stents & scaffolds

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover a selection of cases on stable CAD, stents & scaffolds and learn more about how to cope with complications.

Cases on complications: stable CAD, stents & scaffolds

Abstracts: Use of balloons in Bifurcation Lesions

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover a selection of abstracts on stents, scaffolds and DEB, and learn more about the outcome of balloon-embedded bifurcation stenting with single stent for side branch protection, the differences between biodegradable vs. durable polymer DES with short-term DATP, and more!

Abstracts on stents, scaffolds and DEB

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

08 Oct 2021 – From AICT-AsiaPCR 2021

In this session dedicated to the MASTER DAPT trial, find out more about the clinical study design and results, get acquainted with the new insights of its clinical outcome for high bleeding risk patients, and learn how the results bridge the gap and cover the unmet need for data...

MASTER DAPT trial: dual